Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab ortirofiban)

Authors
Assali, AR Salloum, J Sdringola, S Moustapha, A Ghani, M Hale, S Schroth, G Fujise, K Anderson, HV Smalling, RW Rosales, OR
Citation
Ar. Assali et al., Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab ortirofiban), AM J CARD, 88(8), 2001, pp. 884
Citations number
7
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF CARDIOLOGY
ISSN journal
00029149 → ACNP
Volume
88
Issue
8
Year of publication
2001
Database
ISI
SICI code
0002-9149(20011015)88:8<884:EOCPBP>2.0.ZU;2-N
Abstract
Clopidogrel pretreatment before percutaneous coronary intervention reduced postprocedure major adverse cardiac effects from 14% to 5.5% (p = 0.03) in patients treated with glycoprotein IIb/IIIa antagonists.